143 related articles for article (PubMed ID: 16758382)
1. [Antibiotic prophylaxis in cesarean section -- piperacillin versus piperacillin/tazobactam in 300 cesarean sections].
Wagner KJ; Bier U; Callies R; Regidor PA; Schindler AE
Zentralbl Gynakol; 2006 Jun; 128(3):149-52. PubMed ID: 16758382
[TBL] [Abstract][Full Text] [Related]
2. [Perioperative antibiotic prophylaxis in radical retropubic prostatectomy: a randomised pilot study of perioperative and postoperative administration].
Schenck M; Luetzke A; Ruebben H; Schneider T
Aktuelle Urol; 2011 Jan; 42(1):38-45. PubMed ID: 21267804
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the therapeutic efficacy of the piperacillin/tazobactame combination vs. ampicillin and gentamycin in in the management of post-cesarean endometritis].
Figueroa-Damian R; Villagrana-Zesati R; San Martín-Herrasti JM; Arredondo-Garcia JL
Ginecol Obstet Mex; 1996 May; 64():214-8. PubMed ID: 8925979
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin/tazobactam in the treatment of polymicrobial infections.
Gorbach SL
Intensive Care Med; 1994 Jul; 20 Suppl 3():S27-34. PubMed ID: 7962986
[TBL] [Abstract][Full Text] [Related]
6. Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.
Retamar P; López-Cerero L; Muniain MA; Pascual Á; Rodríguez-Baño J;
Antimicrob Agents Chemother; 2013 Jul; 57(7):3402-4. PubMed ID: 23612190
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic prophylaxis in hernia repair and breast surgery: a prospective randomized study comparing piperacillin/tazobactam versus placebo.
Esposito S; Leone S; Noviello S; Ianniello F; Marvaso A; Cuniato V; Bellitti F
J Chemother; 2006 Jun; 18(3):278-84. PubMed ID: 17129838
[TBL] [Abstract][Full Text] [Related]
8. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Graham DR; Lucasti C; Malafaia O; Nichols RL; Holtom P; Perez NQ; McAdams A; Woods GL; Ceesay TP; Gesser R
Clin Infect Dis; 2002 Jun; 34(11):1460-8. PubMed ID: 12015692
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.
Jansen JP; Kumar R; Carmeli Y
Value Health; 2009; 12(2):234-44. PubMed ID: 20667059
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
[TBL] [Abstract][Full Text] [Related]
11. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
[TBL] [Abstract][Full Text] [Related]
12. Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
Xu ZR; Ran XW; Xian Y; Yan XD; Yuan GY; Mu SM; Shen JF; Zhang BS; Gan WJ; Wang J
J Antimicrob Chemother; 2016 Jun; 71(6):1688-96. PubMed ID: 26888908
[TBL] [Abstract][Full Text] [Related]
13. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
[TBL] [Abstract][Full Text] [Related]
14. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
Tsai HY; Chen YH; Tang HJ; Huang CC; Liao CH; Chu FY; Chuang YC; Sheng WH; Ko WC; Hsueh PR
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):222-6. PubMed ID: 25139843
[TBL] [Abstract][Full Text] [Related]
15. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Siami G; Christou N; Eiseman I; Tack KJ;
Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis.
Machetti M; Majabo MJ; Furfaro E; Solari N; Novelli A; Cafiero F; Viscoli C
J Antimicrob Chemother; 2006 Oct; 58(4):806-10. PubMed ID: 16943210
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
DiNubile MJ; Chow JW; Satishchandran V; Polis A; Motyl MR; Abramson MA; Teppler H
Antimicrob Agents Chemother; 2005 Aug; 49(8):3217-21. PubMed ID: 16048928
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection.
Erasmo AA; Crisostomo AC; Yan LN; Hong YS; Lee KU; Lo CM
Asian J Surg; 2004 Jul; 27(3):227-35. PubMed ID: 15564167
[TBL] [Abstract][Full Text] [Related]
19. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
20. Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship.
Cai T; Verze P; Brugnolli A; Tiscione D; Luciani LG; Eccher C; Lanzafame P; Malossini G; Wagenlehner FM; Mirone V; Bjerklund Johansen TE; Pickard R; Bartoletti R
Eur Urol; 2016 Feb; 69(2):276-83. PubMed ID: 26001610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
